阿糖胞苷与甲氨蝶呤对小鼠白血病L1210的剂量相关协同作用。 - Suppr | 超能文献

Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210.

作者信息

Avery T L, Roberts D

出版信息

Eur J Cancer (1965). 1974 Jul;10(7):425-9. doi: 10.1016/0014-2964(74)90025-5.

DOI:10.1016/0014-2964(74)90025-5

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210.阿糖胞苷与甲氨蝶呤对小鼠白血病L1210的剂量相关协同作用。

Eur J Cancer (1965). 1974 Jul;10(7):425-9. doi: 10.1016/0014-2964(74)90025-5.

2

Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.不同剂量的甲氨蝶呤（NSC - 740）、阿糖胞苷（NSC - 63878）和环磷酰胺（NSC - 26271）对L1210白血病小鼠耐药性的影响。

Cancer Chemother Rep. 1972 Aug;56(4):473-81.

3

Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.

Cancer Chemother Rep. 1971 Dec;55(5):547-55.

4

[Studies on the relationship between therapeutic schedule and antitumor effect of etoposide and cytosine arabinoside in murine L1210 leukemia].[依托泊苷与阿糖胞苷治疗方案对小鼠L1210白血病抗肿瘤作用的关系研究]

Yakugaku Zasshi. 1989 Nov;109(11):865-8. doi: 10.1248/yakushi1947.109.11_865.

5

Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).阿糖胞苷（NSC - 63878）加5 -（3,3 - 二甲基 - 1 - 三氮烯）咪唑 - 4 - 甲酰胺（NSC - 45388）疗法在晚期小鼠L1210白血病中的价值以及与甲氨蝶呤（NSC - 740）或1,3 - 双（2 - 氯乙基）-1 - 亚硝基脲（卡莫司汀；NSC - 409962）序贯剂量联合使用时疗效的增强。

Cancer Chemother Rep. 1973 Sep-Oct;57(3):291-8.

6

Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.

Cancer Res. 1973 Apr;33(4):791-9.

7

Synergy between 5,10-dideaza-5,6,7,8-tetrahydrofolic acid and methotrexate in mice bearing L1210 tumors.5,10-二去氮-5,6,7,8-四氢叶酸与甲氨蝶呤在携带L1210肿瘤小鼠中的协同作用。

Cancer Chemother Pharmacol. 1989;25(3):173-6. doi: 10.1007/BF00689578.

8

Response of lymphoid leukemia L1210 in mice to implantable sustained release cytosine arabinoside capsules.小鼠淋巴白血病L1210对可植入式缓释阿糖胞苷胶囊的反应。

J Surg Oncol. 1978;10(1):1-7. doi: 10.1002/jso.2930100102.

9

Selective chemotherapy for advanced murine L 1210 leukemia by combination of 2' deoxycytidine and lethal doses of cytosine-arabinoside.2'-脱氧胞苷与致死剂量阿糖胞苷联合用于晚期小鼠L1210白血病的选择性化疗。

Biomedicine. 1977 Jul;27(5):179-80.

10

Immunosuppressive activity of methotrexate and arabinosyl cytosine in mice bearing L1210 leukaemia.甲氨蝶呤和阿糖胞苷对荷L1210白血病小鼠的免疫抑制活性

Br J Pharmacol. 1968 Nov;34(3):674P-676P.

引用本文的文献

1

Biochemical interactions between methotrexate and 1-beta-D-arabinofuranosylcytosine in hematopoietic cells of children: a Pediatric Oncology Group study.甲氨蝶呤与1-β-D-阿拉伯呋喃糖基胞嘧啶在儿童造血细胞中的生化相互作用：一项儿科肿瘤学组研究

Cancer Chemother Pharmacol. 1990;27(1):60-6. doi: 10.1007/BF00689278.

2

Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.甲氨蝶呤先于阿糖胞苷时协同细胞杀伤的机制：L1210和人白血病细胞的研究

J Clin Invest. 1979 Sep;64(3):788-97. doi: 10.1172/JCI109525.